Taro Pharmaceutical Industries Ltd (NYSE:TARO)
| 38.47 Delayed Data As of Jun 02 |  +0.29 / +0.76%Today’s Change | 22.89 Today|||52-Week Range 40.16 | +32.47% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Revenue and Income | Net Revenues | 950.8M | 879.4M | 661.9M | 669.9M | |
| Cost of Goods Sold | 154.9M | 193.0M | 181.9M | 205.6M | ||
| Depreciation And Amortization | 14.8M | 14.8M | 16.5M | 18.6M | ||
| Operating Expenses | Gross Income | 781.0M | 671.5M | 463.5M | 445.7M | |
| General Expenses | 163.5M | 156.3M | 158.6M | 153.2M | ||
| Research And Development | 71.2M | 70.6M | 70.4M | 63.2M | ||
| Total Operating Expenses | 333.3M | 364.2M | 357.0M | 377.4M | ||
| Non-Operating Expenses | Operating Income | 617.5M | 515.2M | 304.9M | 292.5M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 3.7M | ||
| Extraordinary Charge | -3.0M | -276.0K | -1.9M | -- | ||
| Interest Expense On Debt | 473.0K | 0.00 | 0.00 | 7.9M | ||
| Other Expenses | 9.7M | 31.2M | -30.9M | 26.9M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 636.8M | 560.8M | 292.4M | 356.9M | |
| Income Taxes | -95.3M | -103.8M | -82.0M | -74.7M | ||
| Minority Interest | -339.0K | -310.0K | -1.1M | -345.0K | ||
| Discontinued Operations | -236.0K | -352.0K | -335.0K | 0.00 | ||
| Net Income | 540.9M | 456.4M | 211.2M | 281.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | -- | -- | 40.2M | 39.0M | |
| Shares To Calculate EPS Diluted | -- | -- | 40.2M | 39.0M | ||
| Earnings Per Share | EPS | $12.62 | $11.05 | $5.26 | $7.23 | |
| EPS Diluted | -- | -- | $5.26 | $7.23 | ||
